Health Condition 1: null- Laryngo Pharyngeal Reflux
Conditions
Interventions
Intervention1: Pantoprazole sodium 40 mg: Tablet Pantoprazole sodium 40 mg BD for 6 weeks
Control Intervention1: Pre treatment sample group: Pre treatment sample group of the same study group act as c
Sponsors
Sree Mookambika Institute of Medical Science
Eligibility
Inclusion criteria
Inclusion criteria: a. Patients with symptoms suggestive of laryngopharyngeal reflux disease with a reflux finding score of more than 7 as per laryngeal endoscopic examination. b. Patients who are between the age group of 18 and 80.
Exclusion criteria
Exclusion criteria: a. Those who were taking proton pump inhibitors for the past one month b. Patients who are hypersensitive to proton pump inhibitors c. Those who are on any regular drugs d. Pregnant women e. Those who have not given consent f. Patients below 18 years of age g. Patients above 80 years of age h. Patients with other co-existing laryngeal pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Laryngeal reflux symptom indexTimepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Laryngeal reflux finding scoreTimepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactDr H S Sabari Nath
Sree Mookambika Institute of Medical Science
Outcome results
None listed